Cancer
News Category
Flow Cytometry Diagnostics Market Poised to Reach $3.5 Billion by 2036, Driven by MRD Testing and Multiparametric Analysis
The global flow cytometry diagnostics market is projected to grow from $1.5 billion in 2026 to $3.5 billion by 2036 at an 8.9% CAGR, fueled by rising ...
GeoVax Reports Q2 2026 Financial Results and Progress on GEO-MVA Pivotal Study
GeoVax advances its GEO-MVA vaccine toward a pivotal immunobridging study under an expedited EMA pathway, while reporting a net loss of $4.4 million f...
Onco-Innovations Advances Lead Oncology Candidate ONC010 Toward Clinical Studies
Onco-Innovations is progressing its lead PNKP inhibitor ONC010 through manufacturing scale-up, formulation optimization, and clinical planning, aiming...
Experimental Immunotherapy Shows Promise for Aggressive Pediatric Brain Cancer
Research published in Nature Medicine indicates that experimental immunotherapy may offer relief for patients with aggressive pediatric brain and spin...
VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration, Reaching Key Milestone for VXA-222
VERAXA Biotech announced that its bispecific antibody-drug conjugate program VXA-222 has reached a key technical milestone under its collaboration wit...
Onco-Innovations Integrates PNKP Inhibition, Nanoparticle Delivery, and AI to Overcome Key Challenges in Cancer Drug Development
Onco-Innovations is advancing ONC010, a PNKP inhibitor delivered via nanoparticles and supported by AI, to address drug resistance, high clinical tria...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech appoints Christoph Erkel, Ph.D., as chief scientific officer to lead development of its BiTAC platform for cancer therapies targeting s...
VERAXA Biotech Gains Regulatory Support for BiTAC®-TCE Development from Germany's Paul-Ehrlich-Institute
VERAXA Biotech's receipt of Scientific Advice from Germany's Paul-Ehrlich-Institute provides early regulatory guidance for its lead BiTAC®-TCE program...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the shift toward preci...
Recent Outbreaks Reveal Critical Gaps in U.S. Public Health Systems, Experts Say
Recent outbreaks of measles, mpox, and HIV have exposed vulnerabilities in public health infrastructure, prompting companies like Co-Diagnostics Inc. ...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select and treat patients with ovarian, primary...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG appointed Christoph Erkel, Ph.D., as chief scientific officer to lead development of its proprietary BiTAC platform technologies for...
iOrganBio Appoints Lee L. Rubin, Ph.D., to Scientific Advisory Board, Enhancing Neurological Expertise
iOrganBio adds leading stem cell biologist Lee L. Rubin to its Scientific Advisory Board, aiming to leverage his expertise in neurodegenerative diseas...
Quantum BioPharma Pioneers Dual Strategy Against Neurological Disorders with Lucid-MS and unbuzzd
Quantum BioPharma is advancing a two-pronged approach to tackle multiple sclerosis and alcohol intoxication effects, with Lucid-MS targeting MS throug...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Everolimus Formulation Sapu003
Oncotelic Therapeutics announced the publication of preclinical data for its intravenous everolimus formulation Sapu003, which aims to overcome pharma...
Dietary Fat Balance Could Influence Immune System Function, Study Finds
A new study indicates that the ratio of polyunsaturated to monounsaturated fats in the diet can affect immune cell membrane composition, potentially i...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma partners with Bayer to test its antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate cancer, potenti...
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC-TCE Development
VERAXA Biotech AG has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC-TCE prog...
Greenwich LifeSciences Provides Update on Phase 3 FLAMINGO-01 Trial for Breast Cancer Immunotherapy
Greenwich LifeSciences announced DSB recommendation to continue its Phase 3 trial without modification and plans to expand enrollment to up to 2,000 p...
Quantum BioPharma Develops Two-Pronged Strategy to Address Unmet Neurological Needs in MS and Alcohol Intoxication
Quantum BioPharma Ltd. is advancing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, targeting millions affected by these neurolo...
WHO-Commissioned Study Finds No Evidence Mobile Phones Cause Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, potentially easing long-...
Michael Svestka, MD, FACS, Named a 2026 Castle Connolly Top Doctor
General surgeon Michael Svestka, MD, FACS, of Virginia Hernia & General Surgery has been recognized as a 2026 Castle Connolly Top Doctor, an honor awa...
Gut microbiome emerges as key player in biliary atresia — could targeting bacteria improve outcomes for infants?
A comprehensive review reveals that gut microbiome dysbiosis is a critical factor in biliary atresia progression and outcomes, suggesting microbiome-m...
World Brain Day: Alzheimer's Association Launches (re)think your brain Initiative to Promote Proactive Brain Health
The Alzheimer's Association introduces the (re)think your brain initiative, translating brain health research into practical habits to help reduce dem...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform from Germany’s Paul-Ehrlich-Institute
VERAXA Biotech (NASDAQ: VRXA) has received Scientific Advice from Germany’s Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on th...
VERAXA Biotech Receives Favorable Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced positive regulatory feedback from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on developme...
Cayenne Wellness Center to Debut Scar Stories Art Exhibit Highlighting Sickle Cell Warriors' Resilience
Cayenne Wellness Center's Scar Stories art exhibit uses portraits and personal narratives to illuminate the physical and emotional impact of sickle ce...
SS Innovations International to Present SSi Mantra Robotic System at Society of Robotic Surgery Annual Meeting
SS Innovations International will showcase its SSi Mantra surgical robotic system at the 2026 Society of Robotic Surgery Annual Meeting, highlighting ...
Gut Microbial Metabolites Linked to Improved Cancer Immunotherapy Response
A study identifies gut bacteria metabolites that enhance cancer immunotherapy sensitivity, offering potential for new treatments.
SS Innovations to Feature SSi Mantra at Society of Robotic Surgery Annual Meeting
SS Innovations International will showcase its SSi Mantra surgical robotic system at the 2026 Society of Robotic Surgery Annual Meeting, highlighting ...
Wildfire Smoke and Summer Heat Create Dangerous Double Threat to Heart Health, American Heart Association Warns
The American Heart Association warns that the combination of wildfire smoke and extreme heat significantly increases cardiovascular risks, citing stud...
NeuroOne Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic, funded by the Children's Cancer Research Fund, to evaluate a novel treatment...
Birmingham OB/Gyn to Open Comprehensive Women's Health Center in Trussville
Birmingham OB/Gyn announces the Trussville Women's Health Center, expanding access to comprehensive women's healthcare including mammography and ultra...
Dr. Jacqueline Youtsos Scholarship Opens National Application Period for Future Physicians
The Dr. Jacqueline Youtsos Scholarship for Medical Students is now accepting applications nationwide, offering a $1,000 award to undergraduate and med...
Tits R Cool Launches Bold Graphic Tees for Men and Women, Supporting Breast Cancer Research
The Peoria-based apparel brand Tits R Cool releases a new collection of edgy graphic t-shirts that combine rebellious design with a mission to support...
Jett Foundation Launches $10.7M Capital Campaign for Jett's Place, a Sanctuary for Duchenne Community
Jett Foundation announced a capital campaign to build Jett's Place, a wellness and retreat center for families affected by Duchenne muscular dystrophy...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline Programs
Nuvectis Pharma announced the pricing of a $100 million public offering to fund development of its NXP100, NXP200, and NXP900 programs, highlighting i...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced favorable interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for advanced EGFR-mutated NSCLC, ...
Growing Evidence Links Respiratory Infections to Cardiovascular Disease, Expert Says
Professor Colin Russell highlights the overlooked connection between respiratory infections and cardiovascular disease, emphasizing the potential of v...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech announced a collaboration with Ardigen to use artificial intelligence for optimizing its BiTAC T-cell engager pipeline, aiming to impro...
Aortic Dissection: A Silent Killer Explained After Senator Lindsey Graham's Death
The sudden death of U.S. Senator Lindsey Graham from an aortic dissection highlights the urgency of recognizing this medical emergency, its risk facto...
NanoViricides Gains Ethics Approval for Phase II Ebola Trial in the DRC
NanoViricides received National Ethics Committee approval in the Democratic Republic of the Congo for a Phase II trial of its oral NV-387 gummies agai...
Thyroid Hormone T3 Shows Promise in Preventing Pediatric Brain Tumor Recurrence
A study finds that the widely prescribed thyroid hormone triiodothyronine (T3) may enhance standard chemotherapy to prevent recurrence in pediatric br...
Onco-Innovations Completes Analytical Reference Standard Program for ONC010, Strengthening CMC Framework
Onco-Innovations Limited announced the completion of its analytical reference standard preparation program for ONC010, a key step in advancing its lea...
New Breast Cancer Classification Based on Cancer-Immunity Cycle Predicts Immunotherapy Response and Identifies Novel Target PSAT1
Researchers developed a framework classifying breast cancer into three subtypes based on the cancer-immunity cycle, enabling prediction of immunothera...
Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence, Enhances Safety in Preclinical Study
A novel feeder-free TIL expansion protocol significantly reduces interleukin-2 dependence while maintaining anti-tumor activity, and combining it with...
Microbiome emerges as key player in cancer development, opening new avenues for precision oncology
A special issue of Cancer Biology & Medicine highlights how the gut and tumor-resident microbiome actively drives cancer progression and treatment res...
Climate Change Intensifies Antimicrobial Resistance Risks in Animal Diseases, New One Health Framework Warns
A new editorial and companion genomic study show that climate change is driving the spread of antimicrobial resistance genes in Salmonella, urging a O...